NASDAQ:HRMY

Harmony Biosciences Earning Date

USA |NASDAQ |USD

HRMY Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $0.29 $0.24 $-0.14
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $80.92M $73.82M $45.61M

Harmony Biosciences's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

HRMY Earnings Date & History Chart

HRMY Earnings & Revenue Forecast

HRMY Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.44 $0.30 $0.58
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $1.09 $0.89 $1.26
Dec 2022 4 $2.84 $1.95 $3.43

HRMY Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $0.40 $0.43 $0.42
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $1.01 $0.96 $0.91
Dec 2022 0 / 1 $2.64 $2.73 $3.09

HRMY Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $92.27M $87.20M $97.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $306.69M $298.10M $315.60M
Dec 2022 4 $502.68M $440.90M $586.20M

HRMY Earnings Date & Revenue History

HRMY Earnings History

|
Show More
Show More

HRMY Revenue History

|
Show More
Show More

Harmony Biosciences Next Earnings Date & Report

HRMY Next Earnings Date & Report Preview: Sep 2021 (FQ)

HRMY's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Harmony Biosciences's next quarterly earnings is $0.29, with a low EPS estimation of $0.22, and a high estimation of $0.34.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $0.29, the last 2 month trend is $0.30, and the 3 month trend is $0.30.

Based on 3 analysts, the average revenue estimation is $80.92M, with a low revenue estimation of $77.40M, and a high estimation of $84.30M.

Harmony Biosciences Previous Earnings Dates & Reports

HRMY Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Harmony Biosciences's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

HRMY's earnings per share (EPS) was $0.24, beating the consensus analysts forecast of $0.17 by 41.18%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 84.62%, and higher than the same period a year before (Jun 2020) by -245.90%.

Revenues were $73.82M, better than the forecast of $68.90M by 7.14%, up by 23.71% from the previous quarter , and up by 94.24% from the same period last year.

The company reported a net income of $14.12M.

Free cash flow for the quarter was $17.87M , compared to $-87.47M last quarter and $4.83M a year before.

HRMY ended the quarter with $195.61M in total debt, an increase of 0.36% compared to the previous quarter.

HRMY Previous Earnings Date & Report Recap: Dec 2020 (FY)

Harmony Biosciences's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

HRMY's earnings per share (EPS) was $-0.05.

Revenues were $159.74M, better than the forecast of $155.30M by 2.86%, and up by 2564.59% from previous year's revenue.

The company reported a net income of $-36.94M.

Harmony Biosciences reported a free cash flow of $-4.99M for its fiscal year, compared to $-202.59M a year ago.

The company ended the fiscal year with $194.25M in total debt, an increase of 98.32% compared to the previous year.